Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Virus Genes ; 60(5): 475-487, 2024 Oct.
Article de Anglais | MEDLINE | ID: mdl-39102085

RÉSUMÉ

DENV infection outcomes depend on the host's variable expression of immune receptors and mediators, leading to either resolution or exacerbation. While the NS3 protein is known to induce robust immune responses, the specific impact of its protease region epitopes remains unclear. This study investigated the effect of recombinant NS3 protease region proteins from all four DENV serotypes on splenocyte activation in BALB/c mice (n = 5/group). Mice were immunized with each protein, and their splenocytes were subsequently stimulated with homologous antigens. We measured the expression of costimulatory molecules (CD28, CD80, CD86, CD152) by flow cytometry, along with IL-2 production, CD25 expression, and examined the antigen-specific activation of CD4 + and CD8 + T cells. Additionally, the expression of IL-1, IL-10, and TGF-ß1 in splenocytes from immunized animals was assessed. Apoptosis was evaluated using Annexin V/PI staining and DNA fragmentation analysis. Stimulation of splenocytes from immunized mice triggered apoptosis (phosphatidylserine exposure and caspase 3/7 activation) and increased costimulatory molecule expression, particularly CD152. Low IL-2 production and low CD25 expression, as well as sustained expression of the IL-10 gene. These results suggest that these molecules might be involved in mechanisms by which the NS3 protein contributes to viral persistence and disease pathogenesis.


Sujet(s)
Apoptose , Antigène CTLA-4 , Virus de la dengue , Souris de lignée BALB C , Rate , Protéines virales non structurales , Animaux , Souris , Rate/immunologie , Rate/virologie , Virus de la dengue/immunologie , Virus de la dengue/génétique , Antigène CTLA-4/génétique , Antigène CTLA-4/immunologie , Protéines virales non structurales/immunologie , Protéines virales non structurales/génétique , Protéines recombinantes/immunologie , Protéines recombinantes/génétique , Immunisation , Dengue/immunologie , Dengue/virologie , Cytokines/métabolisme , Lymphocytes T CD4+/immunologie , Lymphocytes T CD8+/immunologie
2.
Acta Parasitol ; 66(3): 1068-1073, 2021 Sep.
Article de Anglais | MEDLINE | ID: mdl-33616814

RÉSUMÉ

PURPOSE: Leishmaniasis is an infectious disease transmitted by insects that proliferate mainly in impoverished environments of tropical climates. In the absence of an effective vaccine, pharmacological treatment is the main tool to combat this disease. The objective of this work was to analyze the anti-leishmanial activity of 2-chloro-N-[4-(4-chlorophenyl)-2-thiazolyl] acetamide (AT) in promastigotes of Leishmania mexicana. METHODS: The biological activity of the compound was evaluated using a sulphorhodamine B cytotoxicity test and the integrity of the erythrocytes was evaluated by a lysis test. The anti-trypanosomatid activity was evaluated in vitro, a cell death assay was performed by flow cytometry (IP/Annexin V stain) and a parasite growth recovery assay was performed. RESULTS: The AT showed a CC50 value of 0.031 µM for HeLa cells after 24 h of exposure, which did not induce erythrocyte lysis. On the other hand, the AT showed an IC50 value of 0.086 µM for L. mexicana (promastigote form) after 24 h of interaction. The compound was capable of inducing apoptosis in the parasites and did not allow recovery after 24 h of exposure. CONCLUSION: This study provides valuable information with the objective of developing new drugs for the treatment of this disease, although more research on this molecule is needed to improve its biological activity.


Sujet(s)
Antiprotozoaires , Leishmania mexicana , Leishmaniose , Acétamides/usage thérapeutique , Antiprotozoaires/pharmacologie , Antiprotozoaires/usage thérapeutique , Apoptose , Cellules HeLa , Humains
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE